03.09.2012 • News

Business Monitor International Aquires Espicom Business Intelligence

Business Monitor International, a provider of country risk, financial markets and industry research across global markets, has announced the acquisition of Espicom Business Intelligence, a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets.

The financial terms of the transaction have not been disclosed.

The acquisition brings to BMI Espicom's wide-range of information and business intelligence services for the global healthcare industries. In medical technology and devices, Espicom's service features coverage of key operators in 70 country markets, proprietary 5-year forecasts, daily news on key technologies and critical management reports on areas such as advanced wound care, diagnostic products and market access. In pharmaceuticals, Espicom's service features country-level data, therapeutics, generics and biosimilars markets coverage and specialized drug development database services.

 

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.